Filing Details
- Accession Number:
- 0001209191-22-041410
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-06 21:00:23
- Reporting Period:
- 2022-07-01
- Accepted Time:
- 2022-07-06 21:00:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1845337 | Day One Biopharmaceuticals Inc. | DAWN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1655962 | Ii N Charles York | 395 Oyster Point Blvd, Suite 217 South San Francisco CA 94080 | Coo, Cfo And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-07-01 | 1,479 | $20.00 | 336,081 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-07-05 | 800 | $20.00 | 335,281 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.